Position in OABIW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,243
-$5,572 QoQ
Shares Held
19,900
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OABIW Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Saba Capital Management, L.P. holds $561,229 across 2 Biotechnology names. OABIW ranks #2 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
39,640 | $529,986 | |
| 2 | OABIW |
OmniAb, Inc.
This page
|
19,900 | $31,243 |
All Filings in OABIW
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,243 | 19,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,815 | 19,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,840 | 19,900 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,800 | 20,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,000 | 20,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $70,800 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $84,600 | 20,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||